Qi-Min Zhang

Papers

1

Total Citations

3

H-Index

1

About

Qi-Min Zhang is a rising figure in urologic oncology, whose work focuses on the comparative effectiveness of robotic surgical systems—particularly in radical prostatectomy. Zhang’s most cited study, a 2024 systematic review and meta-analysis, directly compares the short-term efficacy of the KangDuo surgical robot with the established da Vinci robotic system. This work is pivotal in evaluating emerging, cost-effective robotic platforms against the global gold standard, addressing critical questions about surgical outcomes, safety, and accessibility in prostate cancer care. With 3 citations already in a short time, the paper signals growing interest in Zhang’s contributions to evidence-based surgical innovation. By synthesizing data on operative time, complication rates, and functional recovery, Zhang provides a rigorous framework for hospitals considering alternative robotic systems—a timely contribution as healthcare systems seek to expand minimally invasive surgery without prohibitive costs. Zhang’s research not only advances urologic practice but also informs technology adoption policies, positioning them as a key voice in the future of robotic-assisted surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
A systematic review and meta-analysis comparing the short-term efficacy of the KangDuo surgical robot with the da Vinci robotic system in radical prostatectomy
3 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago